Total Payments
$11,617
2024 Payments
$535.76
Companies
45
Transactions
268
Medicare Patients
8,143
Medicare Billing
$720,683
Payment Breakdown by Category
Other$5,891 (50.7%)
Food & Beverage$4,853 (41.8%)
Travel$623.97 (5.4%)
Gifts$155.20 (1.3%)
Education$94.08 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $5,891 | 2 | 50.7% |
| Food and Beverage | $4,853 | 252 | 41.8% |
| Travel and Lodging | $623.97 | 3 | 5.4% |
| Gift | $155.20 | 1 | 1.3% |
| Education | $94.08 | 6 | 0.8% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$11,617
264 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Innovative Medical Technologies, LLC | $5,891 | 6 | $0 (2020) |
| Astellas Pharma US Inc | $994.29 | 59 | $0 (2024) |
| NeoTract Inc. | $944.70 | 10 | $0 (2020) |
| PFIZER INC. | $398.31 | 31 | $0 (2024) |
| Teleflex LLC | $371.93 | 8 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $301.66 | 22 | $0 (2024) |
| Janssen Biotech, Inc. | $238.02 | 19 | $0 (2019) |
| ABBVIE INC. | $234.93 | 14 | $0 (2024) |
| Amgen Inc. | $222.12 | 12 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $189.88 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $535.76 | 26 | PFIZER INC. ($97.30) |
| 2023 | $380.01 | 21 | PFIZER INC. ($75.65) |
| 2022 | $867.27 | 31 | Teleflex LLC ($274.46) |
| 2021 | $503.94 | 18 | CVRx, Inc. ($144.32) |
| 2020 | $351.35 | 20 | Astellas Pharma US Inc ($114.82) |
| 2019 | $1,234 | 36 | NeoTract Inc. ($864.09) |
| 2018 | $718.72 | 50 | Astellas Pharma US Inc ($218.11) |
| 2017 | $7,026 | 66 | Innovative Medical Technologies, LLC ($5,891) |
All Payment Transactions
268 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Urology Gynecology | ||||||
| 10/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/14/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.48 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $45.75 | General |
| Category: Urology | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: UROLOGY | ||||||
| 07/09/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: ONCOLOGY | ||||||
| 07/01/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Urology Gynecology | ||||||
| 05/15/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 05/06/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $14.43 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 04/22/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Urology | ||||||
| 04/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: UROTHELIAL CANCER | ||||||
| 04/02/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: UROLOGY | ||||||
| 03/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Urology | ||||||
| 02/20/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 02/14/2024 | Endo Pharmaceuticals Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: UROLOGY | ||||||
| 02/08/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Urology Gynecology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 1,938 | 6,769 | $1.4M | $229,167 |
| 2022 | 31 | 1,939 | 6,108 | $950,794 | $138,106 |
| 2021 | 41 | 2,295 | 6,938 | $1.3M | $198,791 |
| 2020 | 30 | 1,971 | 7,181 | $1.0M | $154,619 |
Total Patients
8,143
Total Services
26,996
Medicare Billing
$720,683
Procedure Codes
144
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 14 | 126 | $418,050 | $54,085 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 300 | 394 | $118,333 | $34,261 | 29.0% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 78 | 494 | $89,676 | $22,296 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 296 | 363 | $64,582 | $19,600 | 30.3% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 28 | 34 | $115,023 | $14,719 | 12.8% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 14 | 14 | $45,934 | $10,796 | 23.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 60 | 62 | $35,627 | $10,051 | 28.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 153 | $28,176 | $7,209 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $26,354 | $6,537 | 24.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 30 | 33 | $36,608 | $6,105 | 16.7% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 23 | 110 | $207,196 | $4,258 | 2.1% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 23 | 23 | $57,383 | $3,669 | 6.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 156 | 191 | $13,004 | $3,442 | 26.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 33 | 34 | $11,905 | $3,360 | 28.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 27 | 27 | $19,236 | $3,131 | 16.3% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 61 | 64 | $15,905 | $2,827 | 17.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 42 | 47 | $18,025 | $2,492 | 13.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 203 | 273 | $8,515 | $2,287 | 26.9% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 36 | 66 | $9,208 | $2,260 | 24.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 16 | 63 | $8,770 | $2,179 | 24.8% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 15 | 15 | $18,013 | $2,023 | 11.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,061 | $1,469 | 29.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 19 | 19 | $10,030 | $1,401 | 14.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,820 | $1,359 | 28.2% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 40 | 45 | $7,507 | $1,270 | 16.9% |
About Dr. Michael Cunningham, M.D
Dr. Michael Cunningham, M.D is a Urology healthcare provider based in Worthington, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366515405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cunningham, M.D has received a total of $11,617 in payments from pharmaceutical and medical device companies, with $535.76 received in 2024. These payments were reported across 268 transactions from 45 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($5,891).
As a Medicare-enrolled provider, Cunningham has provided services to 8,143 Medicare beneficiaries, totaling 26,996 services with total Medicare billing of $720,683. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Worthington, OH
- Active Since 11/16/2006
- Last Updated 02/13/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1366515405
Products in Payments
- UroLift (Device) $973.20
- XTANDI (Drug) $671.50
- Myrbetriq (Drug) $328.51
- UroLift System (Device) $306.11
- MYRBETRIQ (Drug) $277.90
- XIAFLEX (Biological) $266.13
- Prolia (Biological) $203.94
- GEMTESA (Drug) $196.11
- PROVENGE (Drug) $189.88
- Erleada (Drug) $172.31
- JELMYTO (Drug) $166.50
- Rezum (Device) $155.20
- Barostim Neo System (Device) $144.32
- VESICARE (Drug) $127.19
- Tulsa-Pro (Device) $120.81
- AVEED (Biological) $103.57
- Androgel (Drug) $95.28
- ORGOVYX (Drug) $94.39
- BOTOX (Biological) $93.84
- Xtandi (Drug) $91.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Worthington
Dr. Ronney Abaza, M.d, M.D
Urology — Payments: $494,209
Urology $494,209
Dr. Michael Gambla, M.d, M.D
Urology — Payments: $147,906
Urology $147,906
Dr. William Bloch, M.d, M.D
Urology — Payments: $13,940
Urology $13,940
Dr. Matthew Riebel, M.d, M.D
Urology — Payments: $8,836
Urology $8,836
Colin Ryan, M.d, M.D
Urology — Payments: $8,477
Urology $8,477
Jonathan Corbett, Md, MD
Urology — Payments: $3,812
Urology $3,812